Pyridine nucleotides in regulation of cell death and survival by redox and Non-redox reactions

Critical Reviews in Eukaryotic Gene Expression

Volumn 24, Issue 4, 2014, Pages 287-309

  Kujundžić, Renata Novak ^a   Žarković, Neven ^a   Trošelj, Koraljka Gall ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Energy metabolism; Oxidative stress; Poly(ADP ribose) polymerase; Pyridine nucleotide; Sirtuin; Sphingolipid

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PYRIDINE NUCLEOTIDE; SIRTUIN 1; SPHINGOLIPID; NUCLEOTIDE; PYRIDINE DERIVATIVE;

ARTICLE; AUTOPHAGY; BIOSYNTHESIS; CALORIC RESTRICTION; CELL DAMAGE; CELL DEATH; CELL FATE; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; ENERGY METABOLISM; GLYCOLYSIS; GOLGI COMPLEX; HUMAN; HYPOXIA; MALIGNANT TRANSFORMATION; MITOCHONDRIAL MEMBRANE; NON REDOX REACTION; NUCLEAR LOCALIZATION SIGNAL; OXIDATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROTEIN PROCESSING; SPHINGOLIPID METABOLISM; METABOLISM;

CELL DEATH; CELL SURVIVAL; NUCLEOTIDES; OXIDATION-REDUCTION; PYRIDINES; SPHINGOLIPIDS;

EID: 84908217656     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevEukaryotGeneExpr.2014011828     Document Type: Article

References (192)

1. Kourtis N, Tavernarakis N. Cellular stress response pathways and ageing: intricate molecular relationships. EMBO J. 2011;30:2520–31.
2. Selye H. A syndrome produced by diverse nocuous agents. Nature. 1936;138:32.
3. Halliwell B. Biochemistry of oxidative stress. Biochem Soc Trans. 2007;35:1147–50.
4. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408:239–247.
5. Klaunig JE, Kamendulis LM. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol. 2004;44:239–67.
6. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem. 2004;266:37–56.
7. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogram-ming fuels cell growth and proliferation. Cell Metab. 2008;7:11–20.
8. Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell. 2008;134:703–7.
9. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70.
10. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029–33.
11. Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer. 2011;11:85–95.
12. Hamanaka RB, Chandel NS. Cell biology. Warburg effect and redox balance. Science. 2011;334:1219–20.
13. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.
14. Warburg O. On the origin of cancer cells. Science. 1956;123:309–14.
15. Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mito-chondrial physiology, and tumor maintenance. Cancer Cell. 2006;9:425–34.
16. Moreno-Sánchez R, Rodríguez-Enríquez S, Marín-Hernández A, Saavedra E. Energy metabolism in tumor cells. FEBS J. 2007;274:1393–418.
17. de Groof AJ, te Lindert MM, van Dommelen MM, Wu M, Willemse M, Smift AL, Winer M, Oerlemans F, Pluk H, Fransen JA, Wieringa B. Increased OXPHOS activity precedes rise in glycolytic rate in H-RasV12/E1A transformed fbroblasts that develop a Warburg phenotype. Mol Cancer. 2009;8.
18. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, Schumacker PT. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci U S A. 1998;95:11715–20.
19. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, von Kriegsheim A, Hebestreit HF, Mukherji M, Schofeld CJ, Maxwell PH, Pugh CW, Ratcliffe PJ. Targeting of HIF-alpha to the von Hippel-Lindau ubiqui-tylation complex by O2-regulated prolyl hydroxylation. Science. 2001;292:468–72.
20. Lin X, David CA, Donnelly JB, Michaelides M, Chandel NS, Huang X, Warrior U, Weinberg F, Tormos KV, Fesik SW, Shen Y. A chemical genomics screen highlights the essential role of mitochondria in HIF-1 regulation. Proc Natl Acad Sci U S A. 2008;105:174–9.
21. Oka S, Hsu CP, Sadoshima J. Regulation of cell survival and death by pyridine nucleotides. Circ Res. 2012;111:611–27.
22. Okazaki IJ, Moss J. Structure and function of eukaryotic mono-ADPribosyltransferases. Rev Physiol Biochem Pharmacol. 1996;129:51–104.
23. Hassa PO, Hottiger MO. The diverse biological roles of mammalian PARPs, a small but powerful family of poly-ADP-ribose polymerases. Front Biosci. 2008;13:3046–82.
24. Sauve AA. Sirtuin chemical mechanisms. Biochim Bio-phys Acta. 2010;1804:1591–603.
25. Van Brocklyn JR, Williams JB. The control of the balance between ceramide and sphingosine-1-phosphate by sphin-gosine kinase: oxidative stress and the seesaw of cell survival and death. Comp Biochem Physiol B. 2012;163:26–36.
26. Satyanarayana U, Narasinga Rao BS. Dietary tryptophan level and the enzymes of tryptophan NAD pathway. Br J Nutr. 1980;43:107–13.
27. Rongvaux A, Shea RJ, Mulks MH, Gigot D, Urbain J, Leo O, Andris F. Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol. 2002;32:3225–34.
28. Revollo JR, Grimm AA, Imai S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltrans-ferase regulates Sir2 activity in mammalian cells. J Biol Chem. 2004;279:50754–63.
29. Preiss J, Handler P. Biosynthesis of diphosphopyridine nucleotide: I. Identifcation of intermediates. J Biol Chem. 1958;233:488–92.
30. Preiss J, Handler P. Biosynthesis of diphosphopyri-dine nucleotide: II. enzymatic aspects. J Biol Chem. 1958;233:493–500.
31. Bieganowski P, Brenner C. Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. Cell. 2004;117:495–502.
32. Nikiforov A, Dolle C, Niere M, Ziegler M. Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation. J Biol Chem. 2011;286:21767–78.
33. Rongvaux A, Andris F, Van Gool F, Leo O. Reconstructing eukaryotic NAD metabolism. Bioessays. 2003;25:683–90.
34. Shibata K, Hayakawa T, Iwai K. Tissue distribution of the enzymes concerned with the biosynthesis of NAD in rats. Agric Biol Chem. 1986;50:3037–41.
35. Sorci L, Cimadamore F, Scotti S, Petrelli R, Cappellacci L, Franchetti P, Orsomando G, Magni G. Initial-rate kinetics of human NMN adenylyltransferases: substrate and metal ion specificity, inhibition by products and multisubstrate analogues, and isozyme contributions to NAD+ biosynthesis. Biochemistry. 2007;46:4912–22.
36. Zhou T, Kurnasov O, Tomchick DR, Binns DD, Grishin NV, Marquez VE, Osterman AL; Zhang H. Structure of human nicotinamide/nicotinic acid mononucleotide ad-enylyltransferase. Basis for the dual substrate specifcity and activation of the oncolytic agent tiazofurin. J Biol Chem. 2002;277:13148–54.
37. Berger F, Lau C, Dahlmann M, Ziegler M. Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyl-transferase isoforms. J Biol Chem. 2005;280:36334–41.
38. Lau C, Dölle C, Gossmann TI, Agledal L, Niere M, Ziegler M. Isoform-specific targeting and interaction domains in human nicotinamide mononucleotide adenylyl-transferases. J Biol Chem. 2010;285:18868–76.
39. Felici R, Lapucci A, Ramazzotti M, Chiarugi A. Insight into molecular and functional properties of NMNAT3 reveals new hints of NAD homeostasis within human mitochondria. PLoS One. 2013;8:e76938.
40. Rustin P, Parfait B, Chretien D, Bourgeron T, Djouadi F, Bastin J, Rötig A, Munnich A. Fluxes of nicotin-amide adenine dinucleotides through mitochondrial membranes in human cultured cells. J Biol Chem. 1996;271:14785–90.
41. Pittelli M, Felici R, Pitozzi V, Giovannelli L, Bigagli E, Cialdai F, Romano G, Moroni F, Chiarugi A. Pharmacological effects of exogenous NAD on mitochondrial bio-energetics, DNA repair, and apoptosis. Mol Pharmacol. 2011;80:1136–46.
42. Cantó C, Sauve AA, Bai P. Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes. Mol Aspects Med. 2013;34:1168–201.
43. Zhang J. Are poly(ADP-ribosyl)ation by PARP-1 and deacetylation by Sir2 linked? Bioessays. 2003;25:808–14.
44. Rajamohan SB, Pillai VB, Gupta M, Sundaresan NR, Birukov KG, Samant S, Hottiger MO, Gupta MP. SIRT1 promotes cell survival under stress by deacetylation-de-pendent deactivation of poly/ADP-ribose) polymerase 1. Mol Cell Biol. 2009;29:4116–29.
45. Mendoza-Alvarez H, Alvarez-Gonzalez R. Poly(ADP-ri-bose) polymerase is a catalytic dimer and the automodif-cation reaction is intermolecular. J Biol Chem. 1993;268: 22575–80.
46. Ame JC, Rolli V, Schreiber V, Niedergang C, Apiou F, Decker P, Muller S, Hoger T, Menissier-de Murcia J, de Murcia G. PARP-2, a novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase. J Biol Chem. 1999;274:17860–8.
47. Houtkooper RH, Canto C, Wanders RJ, Auwerx J. The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr Rev. 2010;31:194–223.
48. Bai P, Canto C, Oudart H, Brunyanszki A, Cen Y, Thomas C, Yamamoto H, Huber A, Kiss B, Houtkooper RH, Schoonjans K, Schreiber V, Sauve AA, Menissier-de Murcia J, Auwerx J. PARP-1 inhibition increases mi-tochondrial metabolism through SIRT1 activation. Cell Metab. 2011;13:461–8.
49. Zhang T, Kraus WL. SIRT1-dependent regulation of chromatin and transcription: Linking NAD+ metabolism and signaling to the control of cellular functions. Bio-chim Biophys Acta. 2010;1804:1666–75.
50. Hegedũs C, Lakatos P, Oláh G, Tóth BI, Gergely S, Sz-abó E, Bíró T, Szabó C, Virág L. Protein kinase C protects from DNA damage-induced necrotic cell death by inhibiting poly(ADP-ribose) polymerase-1. FEBS Lett. 2008;582:1672–8.
51. Berger F, Lau C, Ziegler M. Regulation of poly(ADP-ribose)polymerase 1 activity by the phosphorylation state of the nuclear NAD biosynthetic enzyme NMN adenylyl transferase 1. Proc Natl Acad Sci U S A. 2007;104:3765–70.
52. Zhang T, Berrocal JG, Yao J, DuMond ME, Krishna-kumar R, Ruhl DD, Ryu KW, Gamble MJ, Kraus WL. Regulation of poly(ADP-ribose) polymerase-1-depen-dent gene expression through promoter-directed recruitment of a nuclear NAD+ synthase. J Biol Chem. 2012;287:12405–16.
53. Zhang T, Berrocal JG, Frizzell KM, Gamble MJ, Du-Mond ME, Krishnakumar R, Yang T, Sauve AA, Kraus WL. Enzymes in the NAD+ salvage pathway regulate SIRT1 activity at target gene promoters. J Biol Chem. 2009;284:20408–17.
54. Jackson MD, Schmidt MT, Oppenheimer NJ, Denu JM. Mechanism of nicotinamide inhibition and transglycosi-dation by Sir2 histone/protein deacetylases. J Biol Chem. 2003;278:50985-50998.
55. Benasik M, Komura H, Shimoyama M, Ueda K. Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase. J Biol Chem. 1992;267:1569–75.
56. Ziegler M. New functions of a long-known molecule. Emerging roles of NAD in cellular signaling. Eur J Bio-chem. 2000;267:1550–64.
57. Pollak N, Dölle C, Ziegler M. The power to reduce: pyridine nucleotides-small molecules with a multitude of functions. Biochem J. 2007;402:205-218.
58. Pollak N, Niere M, Ziegler M. NAD kinase levels control the NADPH concentration in human cells. J Biol Chem. 2007;282:33562–71.
59. Ohashi K, Kawai S, Murata K. Identification and characterization of a human mitochondrial NAD kinase. Nat Commun. 2012;3:1248.
60. Berger F, Ramirez-Hernandez M H, Ziegler M. The new life of a centenarian: signalling functions of NAD(P). Trends Biochem Sci. 2004;29:111–8.
61. Lin SJ, Guarente L. Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease. Curr Opin Cell Biol. 2003;15:241–6.
62. Ying W. NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid Redox Signal. 2008;10:179–206.
63. Magni G, Orsomando G, Raffelli N, Ruggieri S. Enzy-mology of mammalian NAD metabolism in health and disease. Front Biosci. 2008;13:6135–54.
64. Williamson DH, Lund P, Krebs HA. The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem J. 1967;103:514–27.
65. Veech RL, Eggleston LV, Krebs HA. The redox state of free nicotinamide-adenine dinucleotide phosphate in the cytoplasm of rat liver. Biochem J. 1969;115:609–19.
66. Magni G, Orsomando G, Raffaelli N. Structural and functional properties of NAD kinase, a key enzyme in NADP biosynthesis. Mini Rev Med Chem. 2006;6:739–46.
67. Lerner F, Niere M, Ludwig A, Ziegler M. Structural and functional characterization of human NAD kinase. Bio-chem Biophys Res Commun. 2001;288:69–74.
68. Plaut GW, Cook M, Aogaichi T. The subcellular location of isozymes of NADP-isocitrate dehydrogenase in tissues from pig, ox and rat. Biochim Biophys Acta. 1983;760:300–8.
69. Lee SH, Jo SH, Lee SM, Koh HJ, Song H, Park JW, Lee WH, Huh TL. Role of NADP+-dependent isocitrate dehydrogenase (NADP+-ICDH) on cellular defence against oxidative injury by γ -rays. Int J Radiat Biol. 2004;80:635–42.
70. Jo SH, Son MK, Koh HJ, Lee SM, Song IH, Kim YO, Lee YS, Jeong KS, Kim WB, Park JW, Song BJ, Huh TL. Control of mitochondrial redox balance and cellular defense against oxidative damage by mitochondrial NADP+-dependent isocitrate dehydrogenase. J Biol Chem. 2001;276:16168–76.
71. Koh HJ, Lee SM, Son BG, Lee SH, Ryoo ZY, Chang KT, Park JW, Park DC, Song BJ, Veech RL, Song H, Huh TL. Cytosolic NADP+-dependent isocitrate dehydroge-nase plays a key role in lipid metabolism. J Biol Chem. 2004;279:39968–74.
72. Vasiliou V, Nebert DW. Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family. Hum Genomics. 2005;2:138–43.
73. Sládek NE. Aldehyde dehydrogenase-mediated cellular relative insensitivity to the oxazaphosphorines. Curr Pharm Des. 1999;5:607-625.
74. Kamino K, Nagasaka K, Imagawa M, Yamamoto H, Yoneda H, Ueki A, Kitamura S, Namekata K, Miki T, Ohta S. Deficiency in mitochondrial aldehyde dehydro-genase increases the risk for late-onset Alzheimer’s disease in the Japanese population. Biochem Biophys Res Commun. 2000;273:192–6.
75. Frenkel R. Bovine heart malic enzyme. I. Isolation and partial purifcation of a cytoplasmic and a mitochondrial enzyme. J Biol Chem. 1971;246:3069–74.
76. Bukato G, Kochan Z, Swierczynski J. Purification and properties of cytosolic and mitochondrial malic enzyme isolated from human brain. Int J Biochem Cell Biol. 1995;27:47–54.
77. Rydström J. Mitochondrial NADPH, transhydrogenase and disease. Biochim Biophys Acta. 2006;1757:721–6.
78. Geiszt M. NADPH oxidases: new kids on the block. Car-diovasc Res. 2006;71:289–99.
79. Perry DK. The role of de novo ceramide synthesis in chemotherapy-induced apoptosis. Ann NY Acad Sci. 2000;905:91–6.
80. Andrieu-Abadie N, Gouazé V, Salvayre R, Levade T. Ce-ramide in apoptosis signaling: relationship with oxida-tive stress. Free Radic Biol Med. 2001;31:717–28.
81. Mullen TD, Hannun YA, Obeid LM. Ceramide synthases at the centre of sphingolipid metabolism and biology. Biochem J. 2012;441:789–802.
82. Grösch S, Schiffmann S, Geisslinger G. Chain length-specific properties of ceramides. Prog Lipid Res. 2012;51:50–62.
83. D’mello NP, Childress AM, Franklin DS, Kale SP, Pinswasdi C, Jazwinski SM. Cloning and characterization of LAG1, a longevity-assurance gene in yeast. J Biol Chem. 1994;269:15451–9.
84. Singh I, Kishimoto Y. Ceramide synthesis in rat brain: Characterization of the synthesis requiring pyridine nu-cleotide. Arch Biochem Biophys. 1980;220:93–100.
85. Grose JH, Joss L, Velick SF, Roth JR. Evidence that feedback inhibition of NAD kinase controls responses to oxi-dative stress. Proc Natl Acad Sci U S A. 2006;103:7601–6.
86. Tanno O, Ota Y, Kitamura N, Katsube T, Inoue S. Nico-tinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve epidermal permeability barrier. Br J Dermatol. 2000;143:524–31.
87. Fabrias G, Muñoz-Olaya J, Cingolani F, Signorelli P, Casas J, Gagliostro V, Ghidoni R. Dihydrocer-amide desaturase and dihydrosphingolipids: Debutant players in the sphingolipid arena. Prog Lipid Res. 2012;51:82–94.
88. De Luca T, Morre DM, Morre DJ. Reciprocal relationship between cytosolic NADH and ENOX2 inhibition triggers sphingolipid-induced apoptosis in HeLa cells. J Cell Biochem. 2010;110:1504–11.
89. Gillard BK, Clement RG, Marcus DM. Variations among cell lines in the synthesis of sphingolipids in de novo and recycling pathways. Glycobiology. 1998;8:885–90.
90. Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol. 2008;9:139–50.
91. Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind S, Spiegel S. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature. 1996;381:800–3.
92. Mathias S, Peña LA, Kolesnick RN. Signal transduction of stress via ceramide. Biochem J. 1998;335:465–80.
93. Liu B, Andrieu-Abadie N, Levade T, Zhang P, Obeid LM, Hannun YA. Glutathione regulation of neutral sphingo-myelinase in tumor necrosis factor-alpha-induced cell death. J Biol Chem. 1998;273:11313–20.
94. Reynolds CP, Maurer BJ, Kolesnick RN. Ceramide synthesis and metabolism as a target for cancer therapy. Cancer Lett. 2004;206:169–80.
95. Semenza GL. Regulation of cancer cell metabolism by hypoxia-inducible factor 1. Semin Cancer Biol. 2009;19:12–6.
96. Martin-Oliva D, Aguilar-Quesada R, O’valle F, Muñoz-Gámez JA, Martínez-Romero R, García Del Moral R, Ruiz de Almodóvar JM, Villuendas R, Piris MA, Oliver FJ. Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis. Cancer Res. 2006;66:5744–56.
97. Elser M, Borsig L, Hassa PO, Erener S, Messner S, Valov-ka T, Keller S, Gassmann M, Hottiger MO. Poly(ADP-ribose) polymerase 1 promotes tumor cell survival by coactivating hypoxia-inducible factor-1-dependent gene expression. Mol Cancer Res. 2008;6:282–90.
98. Lim JH, Lee YM, Chun YS, Chen J, Kim JE, Park JW. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol Cell. 2010;38:864–78.
99. Gomes AP, Price NL, Ling AJ, Moslehi JJ, Montgomery MK, Rajman L, White JP, Teodoro JS, Wrann CD, Hub-bard BP, Mercken EM, Palmeira CM, de Cabo R, Rolo AP, Turner N, Bell EL, Sinclair DA. Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell. 2013;155:1624–38.
100. Yoon H, Shin SH, Shin DH, Chun YS, Park JW. Differential roles of Sirt1 in HIF-1α and HIF-2α mediated hypoxic responses. Biochem Biophys Res Commun. 2014;444:36–43.
101. Dioum EM, Chen R, Alexander MS, Zhang Q, Hogg RT, Gerard RD, Garcia JA. Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacety-lase sirtuin 1. Science. 2009;324:1289–93.
102. Scortegagna M, Ding K, Oktay Y, Gaur A, Thurmond F, Yan LJ, Marck BT, Matsumoto AM, Shelton JM, Richardson JA, Bennett MJ, Garcia JA. Multiple organ pathology, metabolic abnormalities and impaired homeo-stasis of reactive oxygen species in Epas1–/– mice. Nat Genet. 2003;35:331–40.
103. Anelli V, Gault CR, Cheng AB, Obeid LM. Sphingosine kinase 1 is up-regulated during hypoxia in U87MG gli-oma cells. Role of hypoxia-inducible factors 1 and 2. J Biol Chem. 2008;283:3365–75.
104. Blow JJ, Hodgson B. Replication licensing - defning the proliferative state? Trends Cell Biol. 2002;12:72–8.
105. Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol. 2011;27:441–64.
106. Fulco M, Cen Y, Zhao P, Hoffman EP, McBurney MW, Sauve AA, Sartorelli V. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell. 2008;14:661–73.
107. Nardini M, Spanò S, Cericola C, Pesce A, Massaro A, Millo E, Luini A, Corda D, Bolognesi M. CtBP/BARS: a dual-function protein involved in transcription co-repression and Golgi membrane fssion. EMBO J. 2003;22:3122–30.
108. Brenmoehl J, Hoefich A. Dual control of mitochondrial biogenesis by sirtuin 1 and sirtuin 3. Mitochondrion. 2013;13:755–61.
109. Babenko NA, Shakhova EG. Long-term food restriction prevents aging-associated sphingolipid turnover dysregulation in the brain. Arch Gerontol Geriatr. 2014;58:420–6.
110. Shen Z, Liu C, Liu P, Zhao J, Xu W. Sphingosine 1-phos-phate (S1P) promotes mitochondrial biogenesis in Hep G2 cells by activating Peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α). Cell Stress Chaper-ones. 2014;19:541–8.
111. Kogot-Levin A, Saada A. Ceramide and the mitochon-drial respiratory chain. Biochimie. 2014;100:88–94.
112. Zhang Q, Wang SY, Fleuriel C, Leprince D, Rocheleau JV, Piston DW, Goodman RH. Metabolic regulation of SIRT1 transcription via a HIC1:CtBP corepressor complex. Proc Natl Acad Sci U S A. 2007;104:829–33.
113. Dodson M, Darley-Usmar V, Zhang J. Cellular metabolic and autophagic pathways: traffc control by redox signaling. Free Radic Biol Med. 2013;63:207–21.
114. Hamanaka RB, Chandel NS. Mitochondrial reactive oxygen species regulate hypoxic signaling. Curr Opin Cell Biol. 2009;21:894–9.
115. Circu ML, Maloney RE, Aw TY. Disruption of pyridine nucleotide redox status during oxidative challenge at normal and low-glucose states: implications for cellular adenosine triphosphate, mitochondrial respiratory activity, and reducing capacity in colon epithelial cells. Anti-oxid Redox Signal. 2011;14:2151–62.
116. Módis K, Gero D, Erdélyi K, Szoleczky P, DeWitt D, Szabo C. Cellular bioenergetics is regulated by PARP1 under resting conditions and during oxidative stress. Bio-chem Pharmacol. 2012;83:633–43.
117. Kang MS, Ahn KH, Kim SK, Jeon HJ, Ji JE, Choi JM, Jung KM, Jung SY, Kim DK. Hypoxia-induced neuronal apoptosis is mediated by de novo synthesis of ceramide through activation of serine palmitoyltransferase. Cell Signal. 2010;22:610–8.
118. Ying W, Garnier P, Swanson RA. NAD+ repletion prevents PARP-1-induced glycolytic blockade and cell death in cultured mouse astrocytes. Biochim Biophys Res Commun. 2003;308:809–13.
119. Braidy N, Guillemin GJ, Mansour H, Chan-Ling T, Pol-jak A, Grant R. Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats. PLoS One. 2011;6:e19194.
120. Massudi H, Grant R, Braidy N, Guest J, Farnsworth B, Guillemin GJ. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One. 2012;7:e42357.
121. Lanza IR, Nair KS. Mitochondrial function as a determinant of life span. Pfugers Arch. 2010;459:277–89.
122. Lightle SA, Oakley JI, Nikolova-Karakashian MN. Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging. Mech Ageing Dev. 2000;120:111–25.
123. Sacket SJ, Chung HY, Okajima F, Im DS. Increase in sphingolipid catabolic enzyme activity during aging. Acta Pharmacol Sin. 2009;30:1454–61.
124. García-Ruiz C, Colell A, Marí M, Morales A, Fernández-Checa JC. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione. J Biol Chem. 1997;272:11369–77.
125. Rutkute K, Asmis RH, Nikolova-Karakashian MN. Regulation of neutral sphingomyelinase-2 by GSH: a new insight to the role of oxidative stress in aging-associated inflammation. J Lipid Res. 2007;48:2443–52.
126. Hernández-Corbacho MJ, Jenkins RW, Clarke CJ, Han-nun YA, Obeid LM, Snider AJ, Siskind LJ. Accumulation of long-chain glycosphingolipids during aging is prevented by caloric restriction. PLoS One. 2011;6:e20411.
127. Smolková K, Plecitá-Hlavatá L, Bellance N, Benard G, Rossignol R, Ježek P. Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells. Int J Biochem Cell Biol. 2011;43:950–68.
128. Kraus WL. Transcriptional control by PARP-1: Chroma-tin modulation, enhancer-binding, coregulation, and insulation. Curr Opin Cell Biol. 2008;20:294–302.
129. Krishnakumar R, Kraus WL. The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. Mol Cell. 2010;39:8–24.
130. Ji Y, Tulin AV. The roles of PARP1 in gene control and cell differentiation. Curr Opin Genet Dev. 2010;20:512–8.
131. Kim MY, Zhang T, Kraus WL. Poly(ADP-ribosyl)ation by PARP-1: «PAR-laying» NAD+ into nuclear signal. Genes Dev. 2005;19:1951–67.
132. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science. 2000;290:1717–21.
133. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Au-tophagy fghts disease through cellular self-digestion. Nature. 2008;451:1069–75.
134. Ravikumar B, Sarkar S, Davies JE, Futter M, Gar-cia-Arencibia M, Green-Thompson ZW, Jimenez-Sanchez M, Korolchuk VI, Lichtenberg M, Luo S, Massey DC, Menzies FM, Moreau K, Narayanan U, Renna M, Siddiqi FH, Underwood BR, Winslow AR, Rubinsztein DC. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev. 2010;90:1383–435.
135. Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147:728–41.
136. Mathew R, White E. Autophagy in tumorigenesis and energy metabolism: friend by day, foe by night. Curr Opin Genet Dev. 2011;21:113–9.
137. Rabinowitz JD, White E. Autophagy and metabolism. Science. 2010;330:1344–8.
138. Huang Q, Shen HM. To die or to live: the dual role of poly(ADP-ribose) polymerase-1 in autophagy and necrosis under oxidative stress and DNA damage. Autophagy. 2009;5:273–6.
139. Ng F, Tang BL. Sirtuins’ modulation of autophagy. J Cell Physiol. 2013;228:2262–70.
140. Edinger AL. Starvation in the midst of plenty: making sense of ceramide-induced autophagy by analysing nutrient transporter expression. Biochem Soc Trans. 2009;37:253–8.
141. Bedia C, Levade T, Codogno P. Regulation of autoph-agy by sphingolipids. Anticancer Agents Med Chem. 2011;11:844–53.
142. Taniguchi M, Kitatani K, Kondo T, Hashimoto-Nishimu-ra M, Asano S, Hayashi A, Mitsutake S, Igarashi Y, Ume-hara H, Takeya H, Kigawa J, Okazaki T. Regulation of autophagy and its associated cell death by “sphingolipid rheostat”: reciprocal role of ceramide and sphingosine 1-phosphate in the mammalian target of rapamycin pathway. J Biol Chem. 2012;287:39898–910.
143. Jiang W, Ogretmen B. Autophagy paradox and ceramide. Biochim Biophys Acta. 2014;1841:783–92.
144. Berger NA. Poly(ADP-ribose) in the cellular response to DNA damage. Radiat Res. 1985;101:4–15.
145. Zhou J, Ng S, Huang Q, Wu Y-T, Li Z, Yao SQ, Shen H-M. AMPK mediates a pro-survival autophagy downstream of PARP-1 activation in response to DNA alkylat-ing agents. FEBS Lett. 2013;587:170–7.
146. Formentini L, Macchiarulo A, Cipriani G, Camaioni E, Rapizzi E, Pellicciari R, Moroni F, Chiarugi A. Poly(ADP-ribose) catabolism triggers AMP-dependent mitochon-drial energy failure. J Biol Chem. 2009;284:17668–76.
147. Carling D, Sanders MJ, Woods A. The regulation of AMP-activated protein kinase by upstream kinases. Int J Obes (Lond). 2008;32 Suppl 4:S55–9.
148. Roesch A, Vultur A, Bogeski I, Wang H, Zimmermann KM, Speicher D, Körbel C, Laschke MW, Gimotty PA, Philipp SE, Krause E, Pätzold S, Villanueva J, Krepler C, Fukunaga-Kalabis M, Hoth M, Bastian BC, Vogt T, Herlyn M. Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells. Cancer Cell. 2013;23:811–25.
149. Aichler M, Elsner M, Ludyga N, Feuchtinger A, Zangen V, Maier SK, Balluff B, Schöne C, Hierber L, Brasel-mann H, Meding S, Rauser S, Zischka H, Aubele M, Schmitt M, Feith M, Hauck SM, Ueffng M, Langer R, Kuster B, Zitzelsberger H, Höfer H, Walch AK. Clinical response to chemotherapy in oesophageal adenocarcino-ma patients is linked to defects in mitochondria. J Pathol. 2013;230:410–9.
150. Young MM, Kester M, Wang HG. Sphingolipids: regulators of crosstalk between apoptosis and autophagy. J Lipid Res. 2013;54:5–19.
151. Li Y, Li S, Qin X, Hou W, Dong H, Yao L, Xiong L. The pleiotropic roles of sphingolipid signaling in autophagy. Cell Death Dis. 2014;5:e1245.
152. Ogretmen B, Hannun YA. Biologically active sphingo-lipids in cancer pathogenesis and treatment. Nat Rev Cancer. 2004;4:604–16.
153. Maeurer C, Holland S, Pierre S, Potstada W, Scholich K. Sphingosine-1-phosphate induced mTOR-activation is mediated by the E3-ubiquitin ligase PAM. Cell Signal. 2009;21:293–300.
154. Mizutani H. Mechanism of DNA damage and apop-tosis induced by anticancer drugs through generation of reactive oxygen species. Yakugaku Zasshi. 2007;127:1837–42.
155. Senkal CE, Ponnusamy S, Rossi MJ, Bialewski J, Sinha D, Jiang JC, Jazwinski SM, Hannun YA, Ogretmen B. Role of human longevity assurance gene 1 and C18- ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas. Mol Cancer Ther. 2007;6:712–22.
156. Sentelle RD, Senkal CE, Jiang W, Ponnusamy S, Gencer S, Selvam SP, Ramshesh VK, Peterson YK, Lemasters JJ, Szulc ZM, Bielawski J, Ogretmen B. Ceramide targets autophagosomes to mitochondria and induces lethal mitophagy. Nat Chem Biol. 2012;8:831–8.
157. Éthier C, Tardif M, Arul L, Poirier GG. PARP-1 modulation of mTOR signaling in response to a DNA alkylating agent. PLoS One. 2012;7:e47978.
158. Muñoz-Gámez JA, Rodríguez-Vargas JM, Quiles-Pérez R, Aguilar-Quesada R, Martín-Oliva D, de Murcia G, Menissier de Murcia J, Almendros A, Ruiz de Almodóvar M, Oliver FJ. PARP-1 is involved in autophagy induced by DNA damage. Autophagy. 2009;5:61–74.
159. Rodríguez-Vargas JM, Ruiz-Magaña MJ, Ruiz-Ruiz C, Majuelos-Melguizo J, Peralta-Leal A, Rodríguez MI, Muños- Gámez JA, Ruiz de Almodóvar M, Siles E, Rivas AL, Jäättela M, Oliver FJ. ROS-induced DNA damage and PARP-1 are required for optimal induction of starvation-induced autophagy. Cell Res. 2012;22:1181–98.
160. Meley D, Bauvy C, Houben-Weerts JH, Dubbelhuis PF, Helmond MT, Codogno P, Meijer AJ. AMP-activated protein kinase and the regulation of autophagic proteoly-sis. J Biol Chem. 2006;281:34870–9.
161. Hardie DG. Sensing of energy and nutrients by AMP-activated protein kinase. Am J Clin Nutr. 2011;93:891S–6S.
162. Ruderman NB, Xu XJ, Nelson L, Cacicedo JM, Saha AK, Lan F, Ido Y. AMPK and SIRT1: a long-standing partnership? Am J Physiol Endocrinol Metab. 2010;298:E751–60.
163. Cantó C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, Elliott PJ, Puigserver P, Auwerx J. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature. 2009;458:1056–60.
164. Lan F, Cacicedo JM, Ruderman N, Ido Y. SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J Biol Chem. 2008;283:27628–35.
165. Takeda-Watanabe A, Kitada M, Kanasaki K, Koya D. SIRT1 inactivation induces inflammation through the dysregulation of autophagy in human THP-1 cells. Bio-chem Biophys Res Commun. 2012;427:191–6.
166. Pinton G, Manente AG, Murer B, De Marino E, Mutti L, Moro L. PARP1 inhibition affects pleural mesothelioma cell viability and uncouples AKT/mTOR axis via SIRT1. J Cell Mol Med. 2013;17:233–41.
167. Wu T, Wang XJ, Tian W, Jaramillo MC, Lau A, Zhang DD. Poly(ADP-ribose) polymerase-1 modulates Nrf2-dependent transcription. Free Radic Biol Med. 2013;67C:69–80.
168. Bao LJ, Jaramillo MC, Zhang ZB, Zheng YX, Yao M, Zhang DD, Yi XF. Nrf2 induces cisplatin resistance through activation of autophagy in ovarian carcinoma. Int J Clin Exp Pathol. 2014;7:1502–13.
169. Liu XM, Peyton KJ, Shebib AR, Wang H, Korthuis RJ, Durante W. Activation of AMPK stimulates heme oxygenase-1 gene expression and human endothe-lial cell survival. Am J Physiol Heart Circ Physiol. 2011;300:H84–93.
170. Santidrian AF, Matsuno-Yagi A, Ritland M, Seo BB, LeBoeuf SE, Gay LJ, Yagi T, Felding-Habermann B. Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression. J Clin Invest. 2013;123:1068–81.
171. Dodson M, Liang Q, Johnson MS, Redmann M, Fineberg N, Darley-Usmar VM, Zhang J. Inhibition of glycolysis attenuates 4-hydroxynonenal-dependent autophagy and exacerbates apoptosis in differentiated SH-SY5Y neuro-blastoma cells. Autophagy. 2013;9:1996–2008.
172. Buonvicino D, Formentini L, Cipriani G, Chiarugi A. Glucose deprivation converts poly(ADP-ribose) poly-merase-1 hyperactivation into a transient energy producing process. J Biol Chem. 2013;288:36530–7.
173. Xiao B, Sanders MJ, Underwood E, Heath R, Mayer FV, Carmena D, Jing C, Walker PA, Eccleston JF, Haire LF, Saiu P, Howell SA, Aasland R, Martin SR, Carling D, Gamblin SJ. Structure of mammalian AMPK and its regulation by ADP. Nature. 2011;472:230–3.
174. Shaw RJ. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiol (Oxf). 2009;196:65–80.
175. Lavieu G, Scarlatti F, Sala G, Carpentier S, Levade T, Ghidoni R, Botti J, Codogno P. Regulation of au-tophagy by sphingosine kinase 1 and its role in cell survival during nutrient starvation. J Biol Chem. 2006;281:8518–27.
176. Lépine S, Allegood JC, Park M, Dent P, Milstien S, Spiegel S. Sphingosine-1-phosphate phosphohydrolase-1 regulates ER stress-induced autophagy. Cell Death Differ. 2011;18:350–61.
177. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883–99.
178. Xia P, Gamble JR, Rye KA, Wang L, Hii CS, Cockerill P, Khew-Goodall Y, Bert AG, Barter PJ, Vadas MA. Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway. Proc Natl Acad Sci U S A. 1998;95:14196–201.
179. Pettus BJ, Bielawski J, Porcelli AM, Reames DL, Johnson KR, Morrow J, Chalfant CE, Obeid LM, Hannun YA. The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha. FASEB J. 2003;17:1411–21.
180. Pitson SM, Moretti PA, Zebol JR, Lynn HE, Xia P, Vadas MA, Wattenberg BW. Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J. 2003;22:5491–500.
181. Alvarez SE, Harikumar KB, Hait NC, Allegood J, Strub GM, Kim EY, Maceyka M, Jiang H, Luo C, Kordula T, Milstien S, Spiegel S. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature. 2010;465:1084–8.
182. Heffernan-Stroud LA, Obeid LM. Sphingosine kinase 1 in cancer. Adv Cancer Res. 2013;117:201–35.
183. Liang J, Nagahashi M, Kim EY, Harikumar KB, Yamada A, Huang WC, Hait NC, Allegood JC, Price MM, Avni D, Takabe K, Kordula T, Milstien S, Spiegel S. Sphin-gosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. Cancer Cell. 2013;23:107–20.
184. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, Kagnoff MF, Karin M. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 2004;118:285–96.
185. Popivanova BK, Kitamura K, Wu Y, Kondo T, Kagaya T, Kaneko S, Oshima M, Fujii C, Mukaida N. Blocking TNF-alpha in mice reduces colorectal carcino-genesis associated with chronic colitis. J Clin Invest. 2008;118:560–70.
186. Chiavarina B, Martinez-Outschoorn UE, Whitaker-Menezes D, Howell A, Tanowitz HB, Pestell RG, Sotgia F, Lisanti MP. Metabolic reprogramming and two-compartment tumor metabolism: opposing role(s) of HIF1α and HIF2α in tumor-associated fbroblasts and human breast cancer cells. Cell Cycle. 2012;11:3280–9.
187. Kauppinen A, Suuronen T, Ojala J, Kaarniranta K, Sal-minen A. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal. 2013;25:1939–48.
188. Kauppinen TM, Gan L, Swanson RA. Poly(ADP-ribose) polymerase-1-induced NAD(+) depletion promotes nuclear factor-κB transcriptional activity by preventing p65 deacetylation. Biochim Biophys Acta. 2013;1833:1985–91.
189. Mauro C, Leow SC, Anso E, Rocha S, Thotakura AK, Tornatore L, Moretti M, De Smaele E, Beg AA, Ter-gaonkar V, Chandel NS, Franzoso G. NF-κB controls energy homeostasis and metabolic adaptation by up-regulating mitochondrial respiration. Nat Cell Biol. 2011;13:1272–9.
190. Kawauchi K, Araki K, Tobiume K, Tanaka N. p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation. Nat Cell Biol. 2008;10:611–8.
191. Heffernan-Stroud LA, Helke KL, Jenkins RW, De Costa AM, Hannun YA, Obeid LM. Defining a role for sphin-gosine kinase 1 in p53-dependent tumors. Oncogene. 2012;31:1166–75.
192. Watson DG, Tonelli F, Alossaimi M, Williamson L, Chan E, Gorshkova I, Berdyshev E, Bittman R, Pyne NJ, Pyne S. The roles of sphingosine kinases 1 and 2 in regulating the Warburg effect in prostate cancer cells. Cell Signal. 2013;25:1011–7.